ATE414154T1 - Moraxella (branhamella) catarrhalis antigene - Google Patents

Moraxella (branhamella) catarrhalis antigene

Info

Publication number: ATE414154T1
Authority: AT; Austria
Prior art keywords: branhamella; moraxella; catarrhalis antigen; catarrhalis; antigen
Prior art date: 2001-05-15

Application number

AT02729696T

Other languages

English (en)

Inventor

Denis Martin

Josee Hamel

Bernard Brodeur

Stephane Rioux

Julie Couture

Original Assignee

Id Biomedical Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-15

Filing date

2002-05-15

Publication date

2008-11-15

2002-05-15 Application filed by Id Biomedical Corp filed Critical Id Biomedical Corp

2008-11-15 Application granted granted Critical

2008-11-15 Publication of ATE414154T1 publication Critical patent/ATE414154T1/de

Links

241000588621 Moraxella Species 0.000 title abstract 2
239000000427 antigen Substances 0.000 title 1
102000036639 antigens Human genes 0.000 title 1
108091007433 antigens Proteins 0.000 title 1
238000003745 diagnosis Methods 0.000 abstract 1
229920001184 polypeptide Polymers 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
- C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Immunology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Otolaryngology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Communicable Diseases (AREA)
Ophthalmology & Optometry (AREA)
Oncology (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT02729696T 2001-05-15 2002-05-15 Moraxella (branhamella) catarrhalis antigene ATE414154T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US29065301P	2001-05-15	2001-05-15

Publications (1)

Publication Number	Publication Date
ATE414154T1 true ATE414154T1 (de)	2008-11-15

Family

ID=23116982

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02729696T ATE414154T1 (de)	2001-05-15	2002-05-15	Moraxella (branhamella) catarrhalis antigene

Country Status (10)

Country	Link
US (2)	US7410645B2 (de)
EP (2)	EP1392831B1 (de)
JP (2)	JP2005500024A (de)
CN (2)	CN101063141A (de)
AT (1)	ATE414154T1 (de)
AU (1)	AU2002302236B2 (de)
CA (1)	CA2447017A1 (de)
DE (1)	DE60229845D1 (de)
ES (1)	ES2316563T3 (de)
WO (1)	WO2002092625A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2435063A2 (de) *	2009-05-28	2012-04-04	Intercell AG	Moraxella catarrhalis antigene
CN110527740B (zh) *	2019-09-11	2022-03-22	东北农业大学	一种与印度南瓜强雌基因紧密连锁的分子标记、引物及应用
JP6964161B2 (ja) *	2020-04-06	2021-11-10	旭化成株式会社	検体中のモラクセラ・カタラーリス菌を検出するための抗体、並びに斯かる抗体を用いてモラクセラ・カタラーリス菌を検出するための方法、試薬、及びキット

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4425437A (en)	1979-11-05	1984-01-10	Genentech, Inc.	Microbial polypeptide expression vehicle
US4431739A (en)	1979-11-05	1984-02-14	Genentech, Inc.	Transformant bacterial culture capable of expressing heterologous protein
US4338397A (en)	1980-04-11	1982-07-06	President And Fellows Of Harvard College	Mature protein synthesis
DE69331733T2 (de) *	1992-09-16	2002-08-22	The University Of Tennessee Research Corp., Knoxville	Rekombinantes vielwertiges m-protein-vakzin
IL107026A0 (en) *	1992-09-16	1993-12-28	Univ Tennessee Res Corp	Antigen of hybrid m protein and carrier for group a streptococcal vaccine
US6716433B1 (en) *	1997-09-12	2004-04-06	University Of Tennessee Research Foundation	Group a streptococcal vaccines
CA2671261A1 (en)	1997-11-06	1999-05-20	Novartis Vaccines And Diagnostics S.R.L.	Neisserial antigens
GB9810084D0 (en)	1998-05-11	1998-07-08	Cortecs Uk Ltd	Proteins
GB9817824D0 (en)	1998-08-14	1998-10-14	Smithkline Beecham Biolog	Novel compounds
US6673910B1 (en) *	1999-04-08	2004-01-06	Genome Therapeutics Corporation	Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics
ES2306662T3 (es)	1999-05-24	2008-11-16	Glaxosmithkline Biologicals S.A.	Nuevos compuestos de moraxella catarrhalis.
US6632636B1 (en)	1999-06-18	2003-10-14	Elitra Pharmaceuticals Inc.	Nucleic acids encoding 3-ketoacyl-ACP reductase from Moraxella catarrahalis
GB9921691D0 (en)	1999-09-14	1999-11-17	Smithkline Beecham Sa	Novel compounds
AU8743001A (en) *	2000-08-28	2002-03-13	Aventis Pasteur	Moraxella polypeptides and corresponding dna fragments and uses thereof
GB0103171D0 (en)	2001-02-08	2001-03-28	Smithkline Beecham Biolog	Vaccine composition

2002
- 2002-05-15 CA CA002447017A patent/CA2447017A1/en not_active Abandoned
- 2002-05-15 DE DE60229845T patent/DE60229845D1/de not_active Expired - Fee Related
- 2002-05-15 EP EP02729696A patent/EP1392831B1/de not_active Expired - Lifetime
- 2002-05-15 CN CNA2007101028396A patent/CN101063141A/zh active Pending
- 2002-05-15 WO PCT/CA2002/000706 patent/WO2002092625A2/en not_active Ceased
- 2002-05-15 US US10/477,592 patent/US7410645B2/en not_active Expired - Fee Related
- 2002-05-15 EP EP08168688A patent/EP2025754A3/de not_active Withdrawn
- 2002-05-15 JP JP2002589508A patent/JP2005500024A/ja active Pending
- 2002-05-15 AT AT02729696T patent/ATE414154T1/de not_active IP Right Cessation
- 2002-05-15 CN CNA028116895A patent/CN1514879A/zh active Pending
- 2002-05-15 AU AU2002302236A patent/AU2002302236B2/en not_active Ceased
- 2002-05-15 ES ES02729696T patent/ES2316563T3/es not_active Expired - Lifetime
2008
- 2008-05-13 JP JP2008126155A patent/JP2008289480A/ja active Pending
- 2008-07-15 US US12/173,390 patent/US20090074807A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CN1514879A (zh)	2004-07-21
JP2005500024A (ja)	2005-01-06
DE60229845D1 (de)	2008-12-24
CN101063141A (zh)	2007-10-31
WO2002092625A2 (en)	2002-11-21
AU2002302236B2 (en)	2008-09-25
EP1392831B1 (de)	2008-11-12
US20040236087A1 (en)	2004-11-25
US7410645B2 (en)	2008-08-12
EP2025754A3 (de)	2009-05-13
EP2025754A2 (de)	2009-02-18
JP2008289480A (ja)	2008-12-04
US20090074807A1 (en)	2009-03-19
EP1392831A2 (de)	2004-03-03
CA2447017A1 (en)	2002-11-21
WO2002092625A3 (en)	2003-07-10
ES2316563T3 (es)	2009-04-16

Legal Events

Date	Code	Title	Description
2009-05-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
NO20041917D0 (no)	2004-05-10	Spesifikke midler som binder humant angiopoietin-2
ATE378403T1 (de)	2007-11-15	Transchromosomale transgen-nagetiere zur herstellung von humänen antikörpern
CY1113224T1 (el)	2016-04-13	Νεο αντισωμα αντι-ρlgf
IL148079A0 (en)	2002-09-12	Human ctla-4 antibodies and compositions containing the same
TR200200472T2 (tr)	2002-06-21	Anti-Erb B2 antikorları ile tedavi için dozajlar
EA200300464A1 (ru)	2003-10-30	ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ
DK1368060T3 (da)	2010-08-30	HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme
DE60136054D1 (de)	2008-11-20	Apoptose-induzierendes polypeptid
CY1114614T1 (el)	2016-10-05	Αντιγονα αιμοφιλου ινφλουεντσας και αντιστοιχα dna θραυσματα
ATE477274T1 (de)	2010-08-15	Gegen clostridium difficile gerichtete antikörper
ATE453714T1 (de)	2010-01-15	Antigene aus cryptosporidium parvum, antikörper dagegen und diagnostische und therapeutische zusammensetzungen
BR0113099A (pt)	2004-07-06	Gene e proteìna relacionados com esquizofrenia
ATE414154T1 (de)	2008-11-15	Moraxella (branhamella) catarrhalis antigene
DE60335610D1 (de)	2011-02-17	Neoplasma-spezifische antikörper und deren verwendungen
ATE421586T1 (de)	2009-02-15	Moraxella (branhamella) catarrhalis antigene
DK1276495T3 (da)	2006-08-14	Anvendelse af rekombinante lungesurfactant-præparater til tidlig behandling af akutte lungesygdomme
TR200003345T2 (tr)	2001-03-21	Moraxella Catarrhalıs'in bileşikleri
ATE414155T1 (de)	2008-11-15	Moraxella (branhamella) catarrhalis polypeptide
WO2003018052A8 (en)	2003-08-21	Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
ATE293693T1 (de)	2005-05-15	Moraxella catarrhalis antigen basb117
DE60019613D1 (de)	2005-05-25	Moraxella catarrhalis antigen basb120
DE60035788D1 (de)	2007-09-13	Polypeptide aus moraxella (branhamella) catarrhalis